Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 09/02 04:00:01 pm
359.5 USD   +2.58%
2h agoDJMARKET SNAPSHOT : S&P 500 Falls Back Under 2,000 As Stocks Slip
4h ago S&P 500 MOVERS : Wynn, spls
4h ago NASDAQ 100 MOVERS : Wynn, spls
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Regeneron: Sanofi Plans to Increase Stake to Over $500 Million of Stock

02/11/2013 | 10:44am US/Eastern
Recommend:
0
   By Melodie Warner 
 

Regeneron Pharmaceuticals Inc. (>> Regeneron Pharmaceuticals Inc) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and push its ownership of voting securities to more than $500 million.

Sanofi currently holds about 17% of Regeneron's shares outstanding, according to FactSet Research.

Regeneron said a December 2007 investor agreement bonds the French drug maker to certain standstill provisions, including an agreement not to acquire more than 30% of Regeneron's Class A stock and common stock outstanding.

Regeneron said these standstill provisions are in effect until the fifth anniversary of the expiration of a license and collaboration agreement between the companies.

Sanofi and Regeneron have worked together on experimental cancer drug Zaltrap, among other things.

Shares of Regeneron rose 5.6% to $175.13 in recent trading and have climbed 24% in the past three months.

Write to Melodie Warner at melodie.warner@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

Stocks mentioned in the article : Regeneron Pharmaceuticals Inc
Recommend :
0
React to this article
Latest news on REGENERON PHARMACEUTICALS
2h agoDJMARKET SNAPSHOT : S&P 500 Falls Back Under 2,000 As Stocks Slip
4h ago S&P 500 MOVERS : Wynn, spls
4h ago NASDAQ 100 MOVERS : Wynn, spls
5h agoDJMARKET SNAPSHOT : S&P 500 Dips, But Apple, Staples, Tesla Pop
6h agoDJMARKET SNAPSHOT : S&P 500 Flat After ISM Data; Staples, Regeneron Pop
7h ago REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Present Detailed Positive Res..
1d ago Pricing is key for new heart drugs challenging cheap generics
5d ago REGENERON PHARMACEUTICALS : Assigned Patent
08/25 NASDAQ 100 MOVERS : Intu, gild
08/20 REGENERON PHARMACEUTICALS : Patent Issued for VEGF Antagonist Formulations for I..
Advertisement
Chart
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF